Literature DB >> 15794924

Virus-based reporter systems for monitoring transcriptional activity of hypoxia-inducible factor 1.

O V Razorenova1, A V Ivanov, A V Budanov, P M Chumakov.   

Abstract

Being key regulator of oxygen homeostasis hypoxia-inducible factor 1 (HIF-1) plays significant roles in cancer progression as well as in cardiovascular diseases. The modulation of HIF-1alpha activity in vivo may represent a valuable therapeutic approach to these disorders. In order to monitor HIF-1 transcriptional activity, we have developed HIF-1alpha-responsive reporter constructs, in which lacZ gene expression is driven by minimal Hsp70 gene promoter or minimal immediate early promoter of cytomegalovirus (CMV) and a combination of hypoxia response elements from regulatory regions of PGK1, ENO1 and LDHA genes. For the efficient delivery to a wide variety of cell types we chose retroviral and lentiviral vectors as carriers of the reporter cassette. We demonstrate that the obtained reporter system i) has a high inducibility in response to treatments leading to HIF-1alpha activation, ii) shows upregulation in response to HIF-1 activation and downregulation following inhibition of HIF-1alpha expression by small interfering RNA, iii) follows the dynamics of endogenous HIF-1 target gene expression. The retrovirus- and lentivirus-based reporters can be used for high-throughput screening of HIF-1alpha modulators and for the study of crosstalk between HIF-1 and different related signal transduction pathways. Potential applications for the reporters are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15794924      PMCID: PMC2773277          DOI: 10.1016/j.gene.2005.02.006

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  32 in total

1.  Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer.

Authors:  D M Aebersold; P Burri; K T Beer; J Laissue; V Djonov; R H Greiner; G L Semenza
Journal:  Cancer Res       Date:  2001-04-01       Impact factor: 12.701

Review 2.  HIF-1 and mechanisms of hypoxia sensing.

Authors:  G L Semenza
Journal:  Curr Opin Cell Biol       Date:  2001-04       Impact factor: 8.382

3.  Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy.

Authors:  P Schratzberger; G Schratzberger; M Silver; C Curry; M Kearney; M Magner; J Alroy; L S Adelman; D H Weinberg; A H Ropper; J M Isner
Journal:  Nat Med       Date:  2000-04       Impact factor: 53.440

4.  Therapeutic efficacy of the suicide gene driven by the promoter of vascular endothelial growth factor gene against hypoxic tumor cells.

Authors:  N Koshikawa; K Takenaga; M Tagawa; S Sakiyama
Journal:  Cancer Res       Date:  2000-06-01       Impact factor: 12.701

Review 5.  Activation of the HIF pathway in cancer.

Authors:  P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Curr Opin Genet Dev       Date:  2001-06       Impact factor: 5.578

6.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

7.  Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer.

Authors:  P Birner; M Schindl; A Obermair; C Plank; G Breitenecker; G Oberhuber
Journal:  Cancer Res       Date:  2000-09-01       Impact factor: 12.701

8.  Development of a hypoxia-responsive vector for tumor-specific gene therapy.

Authors:  T Shibata; A J Giaccia; J M Brown
Journal:  Gene Ther       Date:  2000-03       Impact factor: 5.250

9.  Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression.

Authors:  D Zagzag; H Zhong; J M Scalzitti; E Laughner; J W Simons; G L Semenza
Journal:  Cancer       Date:  2000-06-01       Impact factor: 6.860

10.  Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases.

Authors:  H Zhong; A M De Marzo; E Laughner; M Lim; D A Hilton; D Zagzag; P Buechler; W B Isaacs; G L Semenza; J W Simons
Journal:  Cancer Res       Date:  1999-11-15       Impact factor: 12.701

View more
  17 in total

1.  CDCP1 cleavage is necessary for homodimerization-induced migration of triple-negative breast cancer.

Authors:  H J Wright; J Arulmoli; M Motazedi; L J Nelson; F S Heinemann; L A Flanagan; O V Razorenova
Journal:  Oncogene       Date:  2016-02-15       Impact factor: 9.867

2.  In vivo bioluminescence imaging of cell differentiation in biomaterials: a platform for scaffold development.

Authors:  Juli R Bagó; Elisabeth Aguilar; Maria Alieva; Carolina Soler-Botija; Olaia F Vila; Silvia Claros; José A Andrades; José Becerra; Nuria Rubio; Jerónimo Blanco
Journal:  Tissue Eng Part A       Date:  2012-12-21       Impact factor: 3.845

3.  CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation.

Authors:  Heather J Wright; Jue Hou; Binzhi Xu; Marvin Cortez; Eric O Potma; Bruce J Tromberg; Olga V Razorenova
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-24       Impact factor: 11.205

4.  VHL loss in renal cell carcinoma leads to up-regulation of CUB domain-containing protein 1 to stimulate PKC{delta}-driven migration.

Authors:  Olga V Razorenova; Elizabeth C Finger; Renata Colavitti; Sophia B Chernikova; Alexander D Boiko; Charles K F Chan; Adam Krieg; Barbara Bedogni; Edward LaGory; Irving L Weissman; Marianne Broome-Powell; Amato J Giaccia
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-13       Impact factor: 11.205

5.  Trimming of mammalian transcriptional networks using network component analysis.

Authors:  Linh M Tran; Daniel R Hyduke; James C Liao
Journal:  BMC Bioinformatics       Date:  2010-10-13       Impact factor: 3.169

6.  Small-molecule RETRA suppresses mutant p53-bearing cancer cells through a p73-dependent salvage pathway.

Authors:  J E Kravchenko; G V Ilyinskaya; P G Komarov; L S Agapova; D V Kochetkov; E Strom; E I Frolova; I Kovriga; A V Gudkov; E Feinstein; P M Chumakov
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-18       Impact factor: 11.205

7.  Efficient downregulation of multiple mRNA targets with a single shRNA-expressing lentiviral vector.

Authors:  Stepan P Chumakov; Julia E Kravchenko; Vladimir S Prassolov; Elena I Frolova; Peter M Chumakov
Journal:  Plasmid       Date:  2010-01-11       Impact factor: 3.466

8.  The apoptosis repressor with a CARD domain (ARC) gene is a direct hypoxia-inducible factor 1 target gene and promotes survival and proliferation of VHL-deficient renal cancer cells.

Authors:  Olga V Razorenova; Laura Castellini; Renata Colavitti; Laura E Edgington; Monica Nicolau; Xin Huang; Barbara Bedogni; Edward M Mills; Matthew Bogyo; Amato J Giaccia
Journal:  Mol Cell Biol       Date:  2013-12-16       Impact factor: 4.272

9.  [Transcriptional inhibition of human papilloma virus in cervical carcinoma cells reactivates functions of the tumor suppressor p53].

Authors:  D V Kochetkov; G V Il'inskaia; P G Komarov; E Strom; L S Agapova; A V Ivanov; A V Budanov; E I Frolova; P M Chumakov
Journal:  Mol Biol (Mosk)       Date:  2007 May-Jun

10.  Molecular mechanisms of HIF-1alpha modulation induced by oxygen tension and BMP2 in glioblastoma derived cells.

Authors:  Francesca Pistollato; Elena Rampazzo; Sara Abbadi; Alessandro Della Puppa; Renato Scienza; Domenico D'Avella; Luca Denaro; Geertruy Te Kronnie; David M Panchision; Giuseppe Basso
Journal:  PLoS One       Date:  2009-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.